Steven O’Reilly
-
- Systemic Sclerosis and Related Diseases 47
- Autoimmune Bullous Skin Diseases 7
- Dermatology top 1%
- Dermatologic Treatments and Research 10
- Immunology top 5%
- IL-33, ST2, and ILC Pathways 11
- Mast cells and histamine 6
- Cancer Research top 5%
- Rheumatology top 5%
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 18
-
- Connective Tissue Growth Factor Research 6
- Epigenetics and DNA Methylation 6
- Co-authors
- Jacob M. van LaarMarzena CiechomskaRachel CantThomas HügleJohn HendersonMatthew BrownNicola FullardRichard Stratton
- Journals
- Lara D. Veeken (7 papers)Annals of the Rheumatic Diseases (4 papers)Clinical & Experimental Immunology (3 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Steven O’Reilly
75 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 111
- Pathology and Forensic Medicine 1.2k
- Dermatology 436
- Immunology 829
- Cancer Research 312
- Rheumatology 259
Countries citing papers authored by Steven O’Reilly
This map shows the geographic impact of Steven O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven O’Reilly more than expected).
Fields of papers citing papers by Steven O’Reilly
This network shows the impact of papers produced by Steven O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven O’Reilly. The network helps show where Steven O’Reilly may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Steven O’Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 18 | |
| 7 | 2024 | 15 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 8 | |
| 11 | 2022 | 6 | |
| 12 | 2022 | 7 | |
| 13 | 2021 | 8 | |
| 14 | 2021 | 42 | |
| 15 | 2021 | 19 | |
| 16 | 2020 | 19 | |
| 17 | 2020 | 54 | |
| 18 | 2020 | 34 | |
| 19 | 2019 | 115 | |
| 20 | 2014 | 2 |
About Steven O’Reilly
Steven O’Reilly is a scholar working on Pathology and Forensic Medicine, Dermatology, Immunology, Cell Biology and Cancer Research, having authored 77 papers that have together received 2.7k indexed citations. Recurring topics across this work include Systemic Sclerosis and Related Diseases (47 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), IL-33, ST2, and ILC Pathways (11 papers), Dermatologic Treatments and Research (10 papers), Autoimmune Bullous Skin Diseases (7 papers), Connective Tissue Growth Factor Research (6 papers), Epigenetics and DNA Methylation (6 papers) and Mast cells and histamine (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Dermatology (436 citations), Immunology (829 citations), Cancer Research (312 citations) and Rheumatology (259 citations). Steven O’Reilly has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Jacob M. van Laar, Marzena Ciechomska, Rachel Cant, Thomas Hügle, John Henderson, Matthew Brown, Nicola Fullard, Richard Stratton, Stefan Przyborski and Julie C. Worrell. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Clinical & Experimental Immunology, Trends in Molecular Medicine and Clinical Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.